Emerith M. Hungria
Goiania, GO, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Leprosy surveillance study in a highly endemic Brazilian area using leprosy specific serologic tests and IFNγ whole blood assay.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: May 01, 2020
Mast cell heterogeneity and anti-inflammatory annexin A1 expression in leprosy skin lesions.
Journal: Microbial pathogenesis
Published: November 22, 2017
Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.
Journal: Frontiers in immunology
Published: November 08, 2017
Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.
Journal: PLoS neglected tropical diseases
Published: February 14, 2017
Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.
Journal: Diagnostic microbiology and infectious disease
Published: August 31, 2016
Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).
Journal: PLoS neglected tropical diseases
Published: July 25, 2016
Application of Mycobacterium Leprae-specific cellular and serological tests for the differential diagnosis of leprosy from confounding dermatoses.
Journal: Diagnostic microbiology and infectious disease
Published: April 21, 2016
Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Journal: Infectious diseases of poverty
Published: December 29, 2015
Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.
Journal: Memorias do Instituto Oswaldo Cruz
Published: May 19, 2015
Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.
Journal: Diagnostic microbiology and infectious disease
Published: March 25, 2015
Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: December 05, 2013
Last Updated: 09/26/2026